Literature DB >> 11063258

HIP12 is a non-proapoptotic member of a gene family including HIP1, an interacting protein with huntingtin.

V S Chopra1, M Metzler, D M Rasper, A E Engqvist-Goldstein, R Singaraja, L Gan, K M Fichter, K McCutcheon, D Drubin, D W Nicholson, M R Hayden.   

Abstract

Huntingtin-interacting protein I (HIP1) is a membrane-associated protein that interacts with huntingtin, the protein altered in Huntington disease. HIP1 shows homology to Sla2p, a protein essential for the assembly and function of the cytoskeleton and endocytosis in Saccharomyces cerevisiae. We have determined that the HIP1 gene comprises 32 exons spanning approximately 215 kb of genomic DNA and gives rise to two alternate splice forms termed HIP1-1 and HIP1-2. Additionally, we have identified a novel protein termed HIP12 with significant sequence and biochemical similarities to HIP1 and high sequence similarity to Sla2p. HIP12 differs from HIP1 in its pattern of expression both at the mRNA and protein level. However, HIP1 and HIP12 are both found within the brain and show a similar subcellular distribution pattern. In contrast to HIP1, which is toxic in cell culture, HIP12 does not confer toxicity in the same assay systems. Interestingly, HIP12 does not interact with huntingtin but can interact with HIP1. suggesting a potential interaction in vivo that may influence the function of each respective protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063258     DOI: 10.1007/s003350010195

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  17 in total

Review 1.  Huntington's disease.

Authors:  S Davies; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

2.  Bending a membrane: how clathrin affects budding.

Authors:  Lars Hinrichsen; Anika Meyerholz; Stephanie Groos; Ernst J Ungewickell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-30       Impact factor: 11.205

Review 3.  Unconventional functions for clathrin, ESCRTs, and other endocytic regulators in the cytoskeleton, cell cycle, nucleus, and beyond: links to human disease.

Authors:  Frances M Brodsky; R Thomas Sosa; Joel A Ybe; Theresa J O'Halloran
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-02       Impact factor: 10.005

Review 4.  The Phox homology (PX) domain, a new player in phosphoinositide signalling.

Authors:  Y Xu; L F Seet; B Hanson; W Hong
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

5.  An Integrated Bioinformatics and Computational Biology Approach Identifies New BH3-Only Protein Candidates.

Authors:  Robert G Hawley; Yuzhong Chen; Irene Riz; Chen Zeng
Journal:  Open Biol J       Date:  2012-05-04

6.  Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking.

Authors:  Martina Metzler; Bo Li; Lu Gan; John Georgiou; Claire-Anne Gutekunst; Yushan Wang; Enrique Torre; Rebecca S Devon; Rosemary Oh; Valerie Legendre-Guillemin; Mark Rich; Christine Alvarez; Marina Gertsenstein; Peter S McPherson; Andras Nagy; Yu Tian Wang; John C Roder; Lynn A Raymond; Michael R Hayden
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

7.  Clathrin light chains function in mannose phosphate receptor trafficking via regulation of actin assembly.

Authors:  Viviane Poupon; Martine Girard; Valerie Legendre-Guillemin; Sebastien Thomas; Lyne Bourbonniere; Jacynthe Philie; Nicholas A Bright; Peter S McPherson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-28       Impact factor: 11.205

8.  Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model.

Authors:  Sheng Zhang; Mel B Feany; Sudipta Saraswati; J Troy Littleton; Norbert Perrimon
Journal:  Dis Model Mech       Date:  2009-04-06       Impact factor: 5.758

9.  Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1.

Authors:  Teresa S Hyun; Lina Li; Katherine I Oravecz-Wilson; Sarah V Bradley; Melissa M Provot; Anthony J Munaco; Ikuko F Mizukami; Hanshi Sun; Theodora S Ross
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Huntington's Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy.

Authors:  Youssef Sari
Journal:  Int J Biomed Sci       Date:  2011-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.